J.F. Sánchez-Ávila

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis

Diagnosis and Management of Cirrhosis and Its Complications

Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study